中度主动脉瓣狭窄患者长期生存率差
该研究基于澳大利亚国家超声心动图数据库,纳入122,809名男性(平均年龄61±17岁)和118,494名女性(平均年龄62±19岁)患者,根据主动脉瓣平均压差、峰值流速和/或面积评估狭窄严重程度,随访中位1,208天。结果显示,与无主动脉瓣狭窄者相比,轻至重度狭窄患者长期死亡风险增加(调整后风险比1.44至2.09,P<0.001),中度狭窄5年死亡率为56%,重度为67%,提示未治疗的中度狭窄患者生存率同样不佳。
要点
- 中度主动脉瓣狭窄患者5年死亡率达56%,显著高于无狭窄者的19%。
- 狭窄严重程度与长期死亡风险呈递增关系,调整后风险比1.44至2.09。
- 平均压差>20.0 mm Hg即中度狭窄起,全因和心血管死亡风险明显增加。
核心结论
- 未治疗的严重主动脉瓣狭窄与长期生存率差相关,中度狭窄患者同样存在较差的生存率。
研究设计与样本
- 回顾性队列研究,基于澳大利亚国家超声心动图数据库,纳入122,809名男性(平均年龄61±17岁)和118,494名女性(平均年龄62±19岁),排除既往主动脉瓣干预患者,随访中位1,208天(四分位距598至2,177天)。
主要发现
- 轻、中、重度主动脉瓣狭窄分别占6.7%(16,129例)、1.4%(3,315例)和2.6%(6,383例)。
- 与无狭窄者(5年死亡率19%)相比,轻至重度狭窄患者长期死亡风险增加,调整后风险比1.44至2.09,所有比较P<0.001。
- 中度狭窄(平均压差20.0至39.0 mm Hg/峰值流速3.0至3.9 m/s)5年死亡率为56%,重度狭窄(≥40.0 mm Hg、≥4.0 m/s或低流速低梯度重度狭窄时瓣口面积<1.0 cm2)为67%。
- 调整年龄、性别、左心室收缩或舒张功能障碍及主动脉瓣反流后,平均压差>20.0 mm Hg(中度狭窄)即与全因死亡(5年死亡率>50%)和心血管死亡风险显著增加相关。
关键数值与推荐
- 中度狭窄定义:平均压差20.0至39.0 mm Hg或峰值流速3.0至3.9 m/s。
- 重度狭窄定义:平均压差≥40.0 mm Hg、峰值流速≥4.0 m/s,或低流速低梯度重度狭窄时瓣口面积<1.0 cm2。
- 无狭窄者5年死亡率为19%,中度狭窄为56%,重度狭窄为67%。
临床怎么用
- 临床应关注中度主动脉瓣狭窄患者的长期预后,不应仅视为轻度病变而忽视随访。
- 平均压差>20.0 mm Hg时即应警惕全因和心血管死亡风险增加,需加强监测与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Historical data suggesting poor survival in patients with aortic stenosis (AS) who do not undergo treatment are largely confined to patients with severe AS. OBJECTIVES: This study sought to determine the prognostic impact of all levels of native valvular AS. METHODS: Severity of AS was characterized by convention and by statistical distribution in 122,809 male patients (mean age 61 ± 17 years) and 118,494 female patients (mean age 62 ± 19 years), with measured aortic valve (AV) mean gradient, peak velocity, and/or area. The relationship between AS severity and survival was then examined during median 1,208 days (interquartile range: 598 to 2,177 days) of follow-up. Patients with previous aortic valve intervention were excluded. RESULTS: Overall, 16,129 (6.7%), 3,315 (1.4%), and 6,383 (2.6%) patients had mild, moderate, and severe AS, respectively. On an adjusted basis (vs. no AS; 5-year mortality 19%), patients with mild to severe AS had an increasing risk of long-term mortality (adjusted hazard ratio: 1.44 to 2.09; p < 0.001 for all comparisons). The 5-year mortality was 56% and 67%, respectively, in those with moderate AS (mean gradient 20.0 to 39.0 mm Hg/peak velocity 3.0 to 3.9 m/s) and severe AS (≥40.0 mm Hg, ≥4.0 m/s, or AV area <1.0 cm2 in low-flow, low-gradient severe AS). A markedly increased risk of death from all causes (5-year mortality >50%) and cardiovascular disease was evident from a mean AV gradient >20.0 mm Hg (moderate AS) after adjusting for age, sex, left ventricular systolic or diastolic dysfunction, and aortic regurgitation. CONCLUSIONS: These data confirm that when left untreated, severe AS is associated with poor long-term survival. Moreover, they also suggest poor survival rates in patients with moderate AS. (National Echocardiographic Database of Australia [NEDA]; ACTRN12617001387314).
引用
- Strange G, Stewart S, Celermajer D, et al. Poor Long-Term Survival in Patients With Moderate Aortic Stenosis. J Am Coll Cardiol. 2019. PMID: 31491546. doi:10.1016/j.jacc.2019.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。